|199.12||-1.16||-0.58%||Vol 823.47K||1Y Perf 30.54%|
|Jun 18th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||228.40||Analyst Rating||Moderate Buy 2.20|
|Potential %||14.70||Finscreener Ranking||★★+ 47.54|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 52.31|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.43|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★+ 41.76|
|Market Cap||17.00B||Earnings Rating||Sell|
|Price Range Ratio 52W %||75.05||Earnings Date||2nd Aug 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd Aug 2021|
|Estimated EPS Next Report||1.50|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||635.14K|
|Avg. Monthly Volume||935.33K|
|Avg. Quarterly Volume||752.30K|
STERIS plc (Ireland) (NYSE: STE) stock closed at 199.12 per share at the end of the most recent trading day (a -0.58% change compared to the prior day closing price) with a volume of 849.92K shares and market capitalization of 17.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 13000 people. STERIS plc (Ireland) CEO is Walter M. Rosebrough.
The one-year performance of STERIS plc (Ireland) stock is 30.54%, while year-to-date (YTD) performance is 5.05%. STE stock has a five-year performance of 196.67%. Its 52-week range is between 146.12 and 216.74, which gives STE stock a 52-week price range ratio of 75.05%
STERIS plc (Ireland) currently has a PE ratio of 42.90, a price-to-book (PB) ratio of 5.10, a price-to-sale (PS) ratio of 6.36, a price to cashflow ratio of 24.70, a PEG ratio of 2.32, a ROA of 6.43%, a ROC of 8.13% and a ROE of 10.59%. The company’s profit margin is 12.79%, its EBITDA margin is 24.90%, and its revenue ttm is $3.11 Billion , which makes it $31.18 revenue per share.
Of the last four earnings reports from STERIS plc (Ireland), there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.50 for the next earnings report. STERIS plc (Ireland)’s next earnings report date is 02nd Aug 2021.
The consensus rating of Wall Street analysts for STERIS plc (Ireland) is Moderate Buy (2.2), with a target price of $228.4, which is +14.70% compared to the current price. The earnings rating for STERIS plc (Ireland) stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
STERIS plc (Ireland) has a dividend yield of 0.81% with a dividend per share of $1.60 and a payout ratio of 30.00%.
STERIS plc (Ireland) has a Buy technical analysis rating based on Technical Indicators (ADX : 9.43, ATR14 : 3.34, CCI20 : 96.69, Chaikin Money Flow : -0.17, MACD : 0.49, Money Flow Index : 56.43, ROC : 4.15, RSI : 54.61, STOCH (14,3) : 79.57, STOCH RSI : 0.27, UO : 50.32, Williams %R : -20.43), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of STERIS plc (Ireland) in the last 12-months were: Cary L Majors (Option Excercise at a value of $209 160), Cary L Majors (Sold 7 573 shares of value $1 230 997 ), Daniel A. Carestio (Option Excercise at a value of $2 630 085), Daniel A. Carestio (Sold 36 500 shares of value $6 448 703 ), David B. Lewis (Option Excercise at a value of $49 312), David B. Lewis (Sold 1 560 shares of value $302 312 ), J. Adam Zangerle (Option Excercise at a value of $655 727), J. Adam Zangerle (Sold 14 252 shares of value $2 514 856 ), Jacqueline B. Kosecoff (Option Excercise at a value of $98 655), Jacqueline B. Kosecoff (Sold 3 121 shares of value $601 073 ), Julia K. Madsen (Option Excercise at a value of $299 351), Julia K. Madsen (Sold 4 900 shares of value $992 636 ), Julia Madsen (Option Excercise at a value of $299 351), Julia Madsen (Sold 4 900 shares of value $992 636 ), Karen L. Burton (Option Excercise at a value of $0), Karen L. Burton (Sold 4 602 shares of value $825 682 ), Michael J. Tokich (Option Excercise at a value of $1 498 560), Michael J. Tokich (Sold 28 000 shares of value $5 268 945 ), Richard C. Breeden (Sold 45 000 shares of value $6 904 302 ), Walter M. Rosebrough (Option Excercise at a value of $9 819 226), Walter M. Rosebrough (Sold 142 085 shares of value $22 670 740 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.